cholesta-5,8-dien-3 beta-ol has been researched along with 24-hydroxycholesterol in 1 studies
| Studies (cholesta-5,8-dien-3 beta-ol) | Trials (cholesta-5,8-dien-3 beta-ol) | Recent Studies (post-2010) (cholesta-5,8-dien-3 beta-ol) | Studies (24-hydroxycholesterol) | Trials (24-hydroxycholesterol) | Recent Studies (post-2010) (24-hydroxycholesterol) |
|---|---|---|---|---|---|
| 36 | 1 | 8 | 232 | 9 | 120 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, U; Babiker, A; Björkhem, I; Diczfalusy, U; Lütjohann, D; Pikuleva, I; Starck, L; von Bahr, S | 1 |
1 other study(ies) available for cholesta-5,8-dien-3 beta-ol and 24-hydroxycholesterol
| Article | Year |
|---|---|
Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.
Topics: Adolescent; Animals; Cell Line; Child; Child, Preschool; Cholestadienols; Cholestanetriol 26-Monooxygenase; Cholesterol 24-Hydroxylase; COS Cells; Cytochrome P-450 Enzyme System; Dehydrocholesterols; Gene Expression; Humans; Hydroxycholesterols; Infant; Recombinant Proteins; Smith-Lemli-Opitz Syndrome; Steroid Hydroxylases; Substrate Specificity; Transfection | 2001 |